• LOTTE rent-a-car recommends Gangwon-do spring drive courses—just 1-2 hours from Seoul
• Seoul Station branch operates 24/7, 365 days a year for anytime pickup and return
• Incheon Airport branch offers immediate pickup at airport parking upon arrival—luggage cart support available
• Convenient booking via official website and global partners—fully maintained vehicles with comprehensive insurance

SEOUL, South Korea, Feb. 19, 2026 /PRNewswire/ — LOTTE rent-a-car, Korea’s No.1 car rental brand, proposes scenic drive routes for travelers visiting Korea during the late winter and early spring season.

LOTTE rent-a-car holds the top market share in Korea’s rental car industry and recently received the ‘Best Partner Award’ from global travel platform Klook as the sole Korean rental car company, reaffirming its service competitiveness for international customers. The number of foreign customers using LOTTE rent-a-car continues to grow annually, with foreign customers accounting for 25% of total short-term rental car sales in 2025.

This season’s recommended destination is Gangwon-do. With serene mountain landscapes and crisp fresh air, these drive courses showcase Korea’s distinctive natural scenery. Reachable within 1-2 hours from Seoul, they’re perfect even for travelers with tight schedules.

Wonju offers majestic natural views around Mount Chiaksan alongside Guryongsa Temple, a historic sanctuary with 1,500 years of history, making it a popular destination even among Koreans. Cheorwon is famous for the breathtaking Hantangang River Columnar Jointing Trail, designated as a UNESCO Global Geopark. If time permits, we recommend visiting the DMZ, the world’s only remaining division site.

For those planning a rental car journey, we recommend using LOTTE rent-a-car’s Seoul Station or Incheon Airport branches. Both locations offer excellent accessibility immediately upon arrival and are staffed with personnel specialized in serving foreign customers, ensuring smooth communication.

LOTTE rent-a-car Seoul Station Branch is directly connected to the Incheon International Airport Railroad, resulting in exceptionally high usage by foreign tourists. Located just a 3-minute walk from Seoul Station Exit 15, it operates 24 hours a day, 365 days a year—the only branch in the area to do so—allowing vehicle rental and return anytime regardless of flight schedules. A diverse lineup of globally familiar models including Toyota and Tesla Model Y is available. The branch also offers luggage storage service for up to 24 hours, enabling travelers to enjoy Korea “hands-free” without heavy bags.

Incheon Airport Branch provides even more attentive service for travelers weary from long flights. Customers who complete online payment in advance and submit their IDP beforehand can pick up their vehicle immediately at the airport parking lot without visiting the counter. Service desks are located inside both Terminal 1 and Terminal 2, saving time without the need for separate shuttle buses or transfers. Upon departure, staff escort customers directly from the parking lot to the departure gate, and luggage cart service is available when needed, providing seamless care from arrival to departure.

LOTTE rent-a-car has professional staff capable of foreign language consultation and specialized customer service manuals for international clients. The official website (www.lotterentacar.net) operates in 9 languages including English, Chinese, and Japanese, creating a global environment where international customers can smoothly complete the entire process from vehicle reservation to contract management and consultation. Reservations are also available through global partner platforms including Hertz, Booking.com, Klook, Trip.com, DiscoverCars, and KKday.

When renting from LOTTE rent-a-car, various convenient services can be added for an even more comfortable journey. English GPS navigation is provided free of charge, and car seat rental service is available for customers traveling with infants. For cases where pickup and return locations differ, one-way rental service can be selected to efficiently manage travel routes.

All LOTTE rent-a-car vehicles are maintained at all times by 100% nationally certified professional mechanics. The company also provides peace of mind through its nationwide network offering immediate emergency response systems in case of accidents or breakdowns. Additionally, comprehensive insurance coverage and Collision Damage Waiver (CDW) services operate to ensure customer safety and protection. Depending on the program enrolled, a zero-deductible policy applies, allowing travelers to focus on their journey without accident concerns.

A LOTTE rent-a-car representative stated, “Unlike package tours that move according to fixed schedules, rental car travel offers the advantage of moving freely at desired times and routes. We hope travelers will venture beyond Seoul and Jeju to explore various regions such as Gangwon-do and experience Korea’s hidden charms firsthand.”

LOTTE rent-a-car, as Korea’s leading rental car brand, provides comprehensive mobility services to domestic and international customers through approximately 300 branches nationwide and a global partnership network.

About LOTTE rental

LOTTE rental, the only comprehensive rental company in Korea, provides better value with various business portfolios, including auto mobility services that encompass car life, business solution services that support more effi­cient businesses.

LOTTE rent-a-car is creating an innovative car life as the No.1 car rental brand. LOTTE rent-a-car G car, Korea’s ‑first car-sharing brand, is drawing a better mobility service.

LOTTE rental is moving forward as a mobility leader that connects customers’ precious lives.

For more information about LOTTE rental, please visit: https://www.lotterental.com/

• Delivering stable UV measurement in extreme environments up to 250°C with GaN-based technology
• Strengthening its industrial UV measurement portfolio for global smart factory markets

SEOUL, South Korea, Feb. 19, 2026 /PRNewswire/ — Genicom Co., Ltd. (CEO Jung-hwan Son), a specialist in ultraviolet (UV) detection and measurement technologies, announced its participation in AFPE 2026 (Asia Film & Flexible Packaging Expo), to be held in Shanghai, China, from June 24 to 26, 2026. At the event, Genicom will showcase the MG-12 Monitor / LO Probe Series, engineered to deliver reliable and stable UV measurement performance even in extreme industrial heat environments.

GaN-Based Technology for High-Temperature Resilience

The MG-12 Monitor / LO Probe Series incorporates Genicom’s proprietary InAlGaN (Indium Aluminum Gallium Nitride)-based GaN sensor technology, enabling precise UV measurement in environments reaching temperatures of up to 250°C.

As thermal degradation is a common challenge in high-heat industrial processes, Genicom engineered this series with enhanced resilience in mind—from advanced sensor material selection to robust structural design.

Key Features of the MG-12 Series

• Dual Monitoring Display: Simultaneously presents Absolute Power (AP) and Relative Power (RP) for intuitive, real-time UV output tracking.
• Versatile Signal Output: Supports DC voltage (1–5 VDC), current (4–20 mA), and digital (0/5 VDC) outputs, ensuring seamless integration with diverse equipment control systems.
• Industrial Adaptability: A compact probe form factor allows installation in confined spaces within complex industrial machinery.
• Broad Application Spectrum: Optimized for UV lamp monitoring, water sterilization, air purification, and high-precision UV curing operations.

Proven Global Expertise in UV Technology

This showcase follows Genicom’s participation in C-TOUCH & DISPLAY SHENZHEN 2025, where the company introduced its high-temperature UV measurement capabilities to more than 150,000 industry visitors. Through AFPE 2026, Genicom aims to further strengthen its position in the global industrial UV sensor market.

A company representative stated,

“For over 25 years, we have addressed the evolving needs of industrial environments through advanced InAlGaN-based UV detection and measurement technologies. At AFPE 2026, we look forward to demonstrating how stable sensor solutions can expand the scope of industrial UV measurement applications worldwide.”

Detailed information on Genicom’s full UV technology lineup, including its professional UV brand GenUV, is available on the official website.

Website: http://www.geni-uv.com

COLOGNE, Germany, Feb. 19, 2026 /PRNewswire/ — DeepL, a global AI product and research company, today announced its availability in AWS Marketplace. Customers can now access DeepL’s market-leading AI translation and writing assistance solutions via the DeepL API through AWS Marketplace, simplifying the path to procure, deploy, and manage DeepL’s entire Language AI platform in their IT environment.

DeepL’s services integrate highly precise, accurate and secure translations within customers own tools, systems and solutions, reducing adoption bottlenecks. By procuring through AWS, DeepL’s customers benefit from the security, scalability, and global reach of AWS infrastructure. DeepL has also completed the AWS Foundational Technical Review, re-emphasizing its alignment with AWS best practices for security, reliability, and operational excellence.

“DeepL is helping organizations across Europe and beyond break down language barriers and unlock new growth opportunities,” said Gavin Mee, COO at DeepL. “Making DeepL available in AWS Marketplace makes it easier for customers to discover, procure, and deploy our solutions and streamline the path from evaluation to production. Together with AWS, we equip enterprises with cutting-edge AI for their mission-critical business operations, unlocking speed and scale beyond limits.”

“AWS Marketplace has become essential infrastructure for the AI era—helping customers cut through the noise to discover, evaluate, and deploy the AI solutions they need, while giving partners like DeepL a streamlined path to reach enterprise buyers globally,” said Miguel Alava, AWS General Manager Software and Technology companies EMEA. “DeepL’s availability in AWS Marketplace exemplifies this value: customers gain immediate access to world-class translation AI that helps them break down language barriers and scale globally.”

Customers including thatgamecompany, a leading gaming studio are already using DeepL’s API on AWS to enable their gamers to communicate seamlessly in any language while playing.

For more information about DeepL’s offerings in AWS Marketplace, visit DeepL AWS Marketplace.

About DeepL

DeepL is a global AI product and research company focused on building secure, intelligent solutions to complex business problems. Over 200,000 business customers and millions of individuals across 228 global markets today trust DeepL’s Language AI platform for human-like translation, improved writing and real-time voice translation. Building on a history of innovation, quality and security, DeepL continues to expand its offerings beyond the field of Language, including DeepL Agent – an autonomous AI assistant designed to transform the way businesses and knowledge workers get work done. Founded in 2017 by CEO Jarek Kutylowski, DeepL now has over 1,000 passionate employees and is supported by world-renowned investors including Benchmark, IVP, and Index Ventures. For more information on DeepL, visit www.deepl.com.

Logo – https://laotiantimes.com/wp-content/uploads/2026/02/deepl_logo-1.jpg

The acquisition combines institutional AI and alternative data processing to deliver the industry’s first fully integrated wealth intelligence solution.

NEW YORK, Feb. 19, 2026 /PRNewswire/ — BridgeWise, the global leader in AI for wealth, today announced the acquisition of Chicago-based Context Analytics, the top AI-powered alternative data processing company, used by tier-one financial firms including S&P Global Market Intelligence.

By merging BridgeWise’s institutional-grade investment intelligence platform – already embedded in financial institutions across Asia, Europe, and South America – with Context Analytics’ expertise in unstructured financial data processing, the consolidated company now provides a level of asset analysis completeness that stands alone in the industry, setting the stage for the next evolution of AI for financial services. The combined offering delivers a complete solution, from data processing to analytics and engagement, in a single integrated system, establishing the world’s first vertically integrated, wealth-native intelligence infrastructure.

BridgeWise Acquires US-Based Context Analytics to deliver the industry’s first fully integrated wealth AI solution.

The New Benchmark in AI for Wealth

BridgeWise has long set the standard for compliant, multilingual AI recommendations and analysis across more than 70,000 global assets. By integrating Context Analytics, which uses proprietary technology to transform news, social media, and thousands of pages of complex filings into numeric, machine-readable data and timely sentiment scores, BridgeWise is now uniquely capable of decoding the full spectrum of market information, providing a holistic solution for banks, brokers, investment managers, and financial service providers in the capital markets.

Financial institutions have increasingly questioned the use of general-purpose AI models in high-stakes investment decision-making, particularly where explainability, auditability, and oversight are required. While generalist, off-the-shelf LLMs have introduced AI to the mainstream, they lack the domain-specific rigor and governance required for highly regulated environments. BridgeWise provides the only AI-native, fully transparent alternative for a complex, regulated industry that cannot rely on generic models.

“Our vision has always been to provide the most robust financial intelligence on the planet,” said Gaby Diamant, CEO of BridgeWise. “By joining forces with Context Analytics, we have created an end-to-end powerhouse for the global financial ecosystem. This partnership allows us to unify the entire intelligence journey, from the proprietary NLP that decodes the world’s raw text and data sources to the end-users’ most concrete intelligence needs, maintaining a compliant, explainable flow of AI analysis. This represents a fundamental evolution in how every financial institution is leveraging intelligence in its day-to-day client services. By merging these capabilities, we are unlocking a new standard of comprehensive, data-backed, compliant intelligence that allows every investor to see the market with total explainability.”

“Joining BridgeWise allows us to realize the full potential of what we’ve built over the last 13 years,” said Joe Gits, CEO of Context Analytics. “By combining our ability to decode the world’s unstructured financial text and sentiment with BridgeWise’s institutional AI, we are creating a vertically integrated engine that finally bridges the gap between raw information and intelligent action.”

Looking Forward: Unlocking the Future of Personalized Finance

The comprehensive intelligence enabled by BridgeWise’s and Context Analytics’ joint technology serves as a catalyst for launching pAI, BridgeWise’s groundbreaking AI wealth agent, which builds, reviews, and optimizes individual portfolios in a fully personalized, explanatory, and conversational manner. By feeding Context Analytics’ high-fidelity data directly into pAI’s orchestration engine, BridgeWise is transforming how financial institutions deliver personalized wealth-building journeys at scale.

pAI empowers financial institutions to replace static investment paths with adaptive, wealth-native AI journeys. By leveraging this vertical-specific intelligence, banks, brokers, and trading platforms can deliver high-touch, agile wealth-building experiences to millions of users simultaneously, offering real-time onboarding and portfolios that adjust automatically as markets and investor needs evolve. While institutions benefit from a scalable solution that doesn’t drain resources, their clients receive a truly individualized experience.

The acquisition of Context Analytics solidifies BridgeWise as the only partner capable of delivering a 360-degree view of the market through a single, compliant infrastructure, setting the pace for how the world’s leading financial institutions interact with data, technology, and their customers.

About BridgeWise 

BridgeWise is the global leader in AI for wealth, transforming how investors and institutions access and act on financial insights. Using regulatory-compliant, transparent AI to power equity and fund analysis, multilingual tools, and even AI chat for investments, BridgeWise provides trusted investment intelligence to over 50 institutional clients and 25 million end users across more than 15 languages. With offices in Japan, Singapore, the US, London, Brazil, Thailand, Israel, and Dubai, BridgeWise partners with leading global institutions including Japan Exchange Group, SIX, B3, eToro, TASE, and Rakuten Securities.

About Context Analytics

Context Analytics is an AI-driven analytics company that transforms unstructured data into actionable market intelligence for financial professionals. Using advanced natural language processing and proprietary models, the platform delivers real-time and historical insights from sources such as news, filings, and social media. Context Analytics helps investors, traders, and institutions uncover sentiment, identify signals, manage risk, and generate predictive alpha, while maintaining transparency, scalability, and compliance across global markets.

Media Contact
Jensen Matthews PR
Loredana Matei
contact@jensenmatthews.com
+971 585850304

Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU 

DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ — Prolacta Bioscience® today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human milk-based fortifier, as a prescription drug for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. This regulatory milestone was achieved in partnership with the Clinigen Group, which serves as Marketing Authorization Holder and distributor in Japan. PreemieFort is currently marketed under the brand name “Humavant” outside of the U.S., Canada, and Japan.  

The landmark regulatory decision validates the critical role of Prolacta’s 100% human milk-based fortifiers for the most fragile infants and sets a powerful precedent for neonatal intensive care units (NICUs) worldwide.  

“Japan’s approval of PreemieFort as a prescription drug reflects the strength of the clinical evidence and the pharmaceutical grade processing that stands up to the rigor of Japan’s stringent regulatory and quality requirements,” said Scott Elster, CEO of Prolacta Bioscience. ”The pivotal Japanese clinical study adds to the extensive evidence supporting the benefits of Prolacta’s exclusive human milk-based diet for critically ill and fragile premature infants.”   

Clinical evidence generated in Japan from the JASMINE trial (“A Randomized, Controlled Study to Assess Growth and Safety of the Exclusive Human Milk Diet (EHMD) in Very Low Birth Weight (VLBW) Infants”) informed Japan’s world-class Pharmaceuticals and Medical Devices Agency’s (PMDA) review.  The Japanese-led phase III, randomized, controlled, open-label, multicenter trial evaluated growth and safety associated with Prolacta’s 100% human milk-based fortifiers, demonstrating significantly better growth in VLBW infants with no change in morbidity or mortality. 

Japan is recognized as a global leader in neonatal care, with among the highest preterm survival rates and lowest rates of necrotizing enterocolitis (NEC),^1,2 a life-threatening intestinal disease primarily affecting premature infants. By granting pharmaceutical approval to PreemieFort, Japan is affirming that Prolacta’s human milk-based fortifiers, free from cow milk, are not simply a nutritional choice but an Rx medicine in the NICU.   

Japan’s approval includes three Prolacta products — PreemieFort Enteral Solution 6, PreemieFort Enteral Solution 8 (Humavant+6 and Humavant+8 human milk-based fortifiers outside the U.S., Canada, and Japan), and PreemieFort Enteral Solution CF (Humavant CR human milk caloric fortifier outside the U.S., Canada, and Japan) — which provide concentrated nutrition to support growth by delivering essential calories and nutrients, while retaining the highest level of human milk bioactivity.  

The approval demonstrates clinical confidence in the benefits and safety of PreemieFort human milk-based fortifiers across a wider range of vulnerable infants with complex nutritional needs.  

“In the NICU, what we feed our smallest patients can influence their entire life,” said Kate Tauber, MD, MA, professor of pediatrics and director of the Human Milk Program at Bernard and Millie Duker Children’s Hospital. “Human milk-based fortifiers should be held to the same expectations as other therapies, consistent, tightly controlled, and safe. Prolacta’s commitment to pharmaceutical-quality manufacturing requirements helps protect vulnerable infants and supports better outcomes.” 

Prolacta maintains the industry’s strictest quality and safety standards for screening, testing, and processing donor milk — standards that extend through pharmaceutical grade product manufacturing. Together, these controls earned Japan’s prescription drug approval, one of the world’s highest regulatory benchmarks.

About Prolacta Bioscience
Prolacta Bioscience® is the global leader in human milk-based nutrition, dedicated to improving health outcomes for critically ill and premature infants. The company’s 100% human milk-based fortifiers and formulas have been used in more than 125,000 vulnerable premature infants worldwide.³ In a global first, Japan granted Prolacta’s PreemieFort® fortifiers prescription drug status in late 2025 for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. Prolacta operates pharmaceutical-grade human milk processing facilities and maintains the industry’s strictest quality and safety standards, with more than 20 tests to screen donor milk and the use of vat pasteurization to inactivate pathogens and ensure safety. Its vat pasteurization also preserves the bioactive components of human milk that support immune protection, gut development, and growth — benefits that are especially important for premature and medically fragile infants.^4-6  Vat pasteurization keeps human milk closer to its natural state than other processing methods, while still ensuring safety. Prolacta has built a secure, independent donor milk supply chain supported by long-term partnerships with thousands of rigorously screened donors, ensuring ample supply to meet NICU demand. Prolacta’s products have been evaluated in over 30 peer-reviewed clinical studies, demonstrating the short- and long-term health benefits of its patented human milk-based fortifiers and formulas. Learn more online or at X, Instagram, Facebook, TikTok, and LinkedIn. 

Media Contact:
Loren Kosmont
Lkosmont@prolacta.com
310-721-9444 

References  

1. Kusuda S, Bennett MV, Gould JB, et al. Comparative analysis of necrotizing enterocolitis in preterm infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-y
2. Isayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 
3. Data on file; estimated number of premature infants fed Prolacta’s products from January 2007 to May 2025. 
4. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 
5. Liang N, Koh J, Kim BJ, et al. Structural and functional changes of bioactive proteins in donor human milk treated by vat-pasteurization, retort sterilization, ultra-high-temperature sterilization, freeze-thawing and homogenization. Front Nutr. Published online September 15, 2022. doi:10.3389/fnut.2022.926814 
6. Meredith-Dennis L, Xu G, Goonatilleke E, Lebrilla CB, Underwood MA, Smilowitz JT. Composition and variation of macronutrients, immune proteins, and human milk oligosaccharides in human milk from nonprofit and commercial milk banks. J Hum Lact. 2018;34(1):120-129. doi:10.1177/0890334417710635 

Logo – https://laotiantimes.com/wp-content/uploads/2026/02/prolacta_bioscience_logo.jpg

NORWALK, Conn., Feb. 19, 2026 /PRNewswire/ — Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced that it has co-led Sift Biosciences’ oversubscribed $3.7 million Pre-Seed financing alongside Freeflow Ventures, with participation from Valuence Ventures, Eisai Innovation, SBI US Gateway Fund, and other early investors.

Sift Biosciences is developing a peptide-based immunotherapy platform designed to harness pre-existing immune memory. The company’s approach aims to generate more consistent immune engagement by activating memory T cells that already exist in patients, with potential applications across oncology and autoimmune disease. Sift is initially advancing programs in immunologically “cold” solid tumors, including microsatellite-stable colorectal and ovarian cancers, while also exploring immune disease programs where more selective control of immune responses could be therapeutic.

“This financing will support in vivo efficacy studies, expansion of our AI powered peptide discovery engine, and lead candidate selection,” said Clare Lou, Ph.D., CEO and Cofounder of Sift Biosciences. “We are excited to partner with Lifespan Vision Ventures and this strong investor syndicate as we advance our initial pipeline toward the clinic.”

“We are pleased to support Sift because they are applying a clear immunology insight with a platform built to scale,” said Altar Munis, Ph.D., Associate at Lifespan Vision Ventures. “The platform is designed to engage antigen-experienced memory T cells and tune response magnitude and phenotype, with potential applications beyond oncology in autoimmunity and broader immune dysfunction that increases with age.”

As part of the financing, Altar Munis, Ph.D., Associate at Lifespan Vision Ventures, and Kevin Barrett, Managing Partner at Freeflow Ventures will join Sift Biosciences’ Board of Directors.

About Lifespan Vision Ventures

Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven solutions that promote healthy aging and extend human healthspan.

Contact: info@lifespanvision.com

Customer-driven recognition reinforces Vantagepoint’s leadership in delivering speed, clarity, and control for project-based architecture, engineering, and consulting businesses  

HERNDON, Va., Feb. 19, 2026 /PRNewswire/ — Deltek, the intelligent platform for project-based businesses, today announced that Deltek Vantagepoint has been named to G2’s 2026 Best Software Awards, earning a place on the Best ERP Software Products list.

Deltek Vantagepoint: Designed for Project-Based Businesses

This award highlights the exceptional satisfaction and trust Vantagepoint has earned from customers worldwide. Built to deliver unmatched speed, clarity, and control across the entire project lifecycle, Vantagepoint helps project-based businesses within professional services industries streamline how they win, plan, execute, and analyze work—all within a modern, intuitive experience that puts usability and intelligence at the forefront.

By unifying CRM, project management, resource planning, financials, and analytics into a single application, Vantagepoint eliminates operational silos and delivers connected insights that support smarter decisions.

“Our goal has always been to deliver intuitive, intelligent solutions that help companies operate with clarity and confidence,” said Bob Hughes, Deltek President and CEO. “This recognition for Vantagepoint is especially meaningful because it comes directly from our customers—the companies that rely on Deltek every day to power their projects, their people, and their performance. We’re grateful for their trust and excited to continue building solutions that deliver real, measurable impact.”

Why Recognition from G2 Matters

As the world’s largest and most trusted software marketplace, G2 reaches over 100 million buyers annually. Its annual Best Software Awards rank the world’s best software companies and products based on verified, high-quality customer reviews. 

Each year, thousands of solutions are evaluated using transparent criteria, including:

• Review volume
• Satisfaction scores
• Market presence and adoption

The Best ERP Software Products list represents one of the most competitive categories, and only the highest-performing, most customer-loved solutions rise to the top.

G2’s 2026 Best Software Awards rank software vendors and products using G2’s proprietary scoring algorithm that analyzes authenticated user sentiment alongside publicly available market data. This ensures the rankings reflect products that consistently deliver measurable customer impact.

G2’s awards reflect authentic, timely feedback from millions of software buyers—only the top ~1% of over 150,000 vendors listed on the platform earn a place on its lists.

“As buyers increasingly shift to AI-driven research to discover software solutions, being recommended in the ‘answer moment’ must be earned with credible proof,” said Godard Abel, co-founder and CEO at G2. “Our Best Software Awards are grounded in trusted data from authentic customer reviews. They not only give buyers an objective, reliable guide to the products that help teams do their best work, but they’re also the proof AI search platforms rely on when sourcing answers. Congratulations to this year’s winners, including Deltek Vantagepoint. Earning a spot on these lists signals real customer impact.”

Learn more about Vantagepoint.

About Deltek

Deltek is the intelligent platform that powers the project lifecycle—from ERP and accounting to project bidding, planning, delivery, and analysis. Trusted by 30,000 organizations across government contracting, aerospace and defense, architecture and engineering, construction, and consulting, Deltek delivers the speed, clarity, and control needed when the stakes are high. Learn more at www.deltek.com.

Media Contact

press@deltek.com